From Feb. 12, 2022, fully vaccinated travelers are no longer requested to present a negative COVID test prior to boarding a flight from the US to France.

You are considered fully vaccinated:

  • 28 days after one dose of the Janssen vaccine,
  • 7 days after the second dose for the other vaccines recognized by the European Medicines Agency (EMA) (Pfizer/Comirnaty, Moderna, AstraZeneca/Vaxzevria/Covishield).
  • For people who have received all the required doses of a vaccine authorized by the WHO which has not been recognized by the EMA, 7 days after one additional dose of a messenger RNA vaccine recognized by the EMA.

The measures applicable to vaccinated adults also apply to any minors accompanying them, whether they are vaccinated or not.

Reminder – Do not forget to apply for your health pass before leaving the United States. At the date of this article, you need in multiple circumstances, a valid Covid Certificate in France if you are over 16. To find out more about the application procedure for a health pass, consult France Diplomatie.

If they do not present a complete vaccination schedule, travelers aged twelve or over, coming from the United States must present at the time of boarding, the negative result of a PCR, LAMP test, or an antigen test (TAG ) performed less than 48 hours before the flight.

Unvaccinated travelers:

  • must have pressing grounds to travel; the list of pressing grounds is set out in the certificate of international travel drawn up by the Ministry of the Interior.
  • might be subject to random antigen testing upon arrival;
  • will have to isolate in case of positive testing upon arrival.

In order to facilitate administrative procedures, they are asked to register before departure on the digital platform éOSCOVID.

Find all the details on the website of the Consulate General of France in San Francisco.

Subscribe to our Newsletter Receive the Latest News from MerciSF

You have Successfully Subscribed!

Inscrivez-vous à notre newsletter pour recevoir les dernières infos de MerciSF

You have Successfully Subscribed!